skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Failure of low doses of /sup 131/I to ablate residual thyroid tissue following surgery for thyroid cancer

Conference · · Radiology; (United States)
OSTI ID:6687669

Thirteen patients received an initial dose of 25-29.9 mCi (925-1106 MBq) of /sup 131/I following partial thyroidectomy for papillary, follicular, or mixed carcinoma. Administration of thyroxine (T/sub 4/) or triiodothyronine (T/sub 3/) was stopped 3-12 weeks and 1-6 weeks, respectively, before therapy or imaging. Patients remained on normal diets and did not receive thyroid stimulating hormone (TSH) or diuretics. Follow-up 3 months to 2 years after therapy demonstrated that ablation of thyroid bed activity was successful in only one patient, who still had metastases. This suggests that administration of 25-29.9 mCi of /sup 131/I following surgery is unreliable for ablation of residual thyroid bed activity.

Research Organization:
Veterans Administration Medical Center, Denver, CO
OSTI ID:
6687669
Journal Information:
Radiology; (United States), Vol. 137:3; Conference: 65. scientific assembly and annual meeting of the Radiological Society of North America, Atlanta, GA, USA, 25 Nov 1979
Country of Publication:
United States
Language:
English

Similar Records

Serial TSH determination after T/sub 3/ withdrawal or thyroidectomy in the therapy of thyroid carcinoma. [I-131]
Journal Article · Sat Sep 01 00:00:00 EDT 1979 · J. Nucl. Med.; (United States) · OSTI ID:6687669

Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Journal Article · Wed Apr 01 00:00:00 EST 1981 · Clin. Nucl. Med.; (United States) · OSTI ID:6687669

Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Journal Article · Wed Apr 01 00:00:00 EST 1981 · Clin. Nucl. Med.; (United States) · OSTI ID:6687669